Quote For Crucell NV CRCL.AS
Crucell NV (CRCL.AS) (Amsterdam Stock Exchange)
sector: Healthcare ·
industry: Biotechnology ·
€14.41
30 Nov 2009
-0.31%
€14.46
€14.40
486,647
€14.45
€14.20
€17.61
€9.55
0.56
262,188
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Oosterveld, Jan | Chairman of the Supervisory Board | 54,200 |
| Brus, Ronald | Chairman of the Management Committee and Management Board, President & Chief Executive Officer | 883,000 |
| Lance, Sean | Vice Chairman of the Supervisory Board | 34,000 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | €1,175.13 |
| Shares Outstanding (Mil.) | 81.27 |
| Float (Mil.) | 80.70 |
| Dividend Information | |
|---|---|
| Yield % | -- |
| Annual Dividend (€ EUR) | 0.00 |
| Payout Ratio(TTM) % | 0.00 |
| Financial Strength | |
|---|---|
| Quick Ratio | 1.95 |
| Current Ratio | 4.44 |
| LT Debt/Equity | 4.77 |
| Total Debt/Equity | 7.26 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | 34.97 |
| Price/Sales(TTM) | 3.65 |
| Price/Book(TTM) | 1.64 |
| Price/Cash Flow(TTM) | 19.71 |
| Per Share Data | |
|---|---|
| Earnings(TTM) | €0.42 |
| Sales(TTM) | €4.83 |
| Book Value(MRQ) | €8.83 |
| Cash Flow(TTM) | €0.89 |
| Cash(MRQ) | €5.07 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | 4.83 |
| Return on Assets(TTM) | 3.51 |
| Return on Investment(TTM) | 4.15 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 46.00 |
| Operating Margin(TTM) % | 10.33 |
| Profit Margin(TTM) % | 8.55 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
